Sodium fluorescein-guided resection of brain metastases: A needed approach or an option? A systematic review and meta-analysis.
Acta Neurochir (Wien)
; 166(1): 334, 2024 Aug 12.
Article
en En
| MEDLINE
| ID: mdl-39133319
ABSTRACT
PURPOSE:
Brain metastases (BM) often leave residual tumors despite having visible margins, which increases the risk of local tumor recurrence and can impact overall patient survival rates. Fluorescence-guided surgery (FGS) utilizing sodium fluorescein (FL) has been reported as an effective technique in recent studies. This study aimed to evaluate the efficacy of FL FGS in improving the extent of resection of brain metastases and its impact on overall survival.METHODS:
We conducted a systematic search following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Our primary focus was on gross total resection (GTR). Additionally, we extracted survival data and evaluated the risk of bias using a modified version of the Joanna Briggs Institute critical appraisal tool.RESULTS:
The study comprised 970 patients with brain metastases through eight different studies. The study found that patients who underwent FL-guided resection had a significantly higher rate of GTR (OR 2.02, 95% CI 1.14-3.56, p = 0.0156, I2 = 41.5%). Additionally, the study concluded that FL-guided resection is associated with better overall survival rates (HR 0.61, 95%CI 0.47 0.80, p = 0.0003, I2 = 41.5%).CONCLUSION:
Our research suggests that the use of FL is associated with a higher rate of GTR and improved overall patient survival. None of the studies we reviewed reported significant complications associated with the use of FL in patients.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Encefálicas
/
Fluoresceína
Límite:
Humans
Idioma:
En
Revista:
Acta Neurochir (Wien)
Año:
2024
Tipo del documento:
Article
País de afiliación:
Irán
Pais de publicación:
Austria